Skip to main content
Top
Published in: Inflammation Research 3/2012

01-03-2012 | Original Research Paper

A20 and ABIN-3 possibly promote regression of trehalose 6,6′-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1

Authors: Yusuke Sakai, Kazuyuki Uchida, Hiroyuki Nakayama

Published in: Inflammation Research | Issue 3/2012

Login to get access

Abstract

Objective

The objective of this paper is to examine the role of NF-kappa B inhibitors A20 and ABIN-family proteins in the trehalose 6,6′-dimycolate (TDM)-induced model of tuberculous granulomatous lesions.

Materials and methods

BALB/c mice were twice injected i.p. with w/o/w emulsions that contain TDM at a 1 week-interval. The mice were killed at days 0, 3, 7, 14, or 21 after the last injection. The mRNA and protein levels of A20 and ABIN-family proteins were measured by real-time PCR using mRNA or protein extract from the lesions. The activation status of NF-kappa B was analyzed by Western blotting and immunohistochemistry. Finally, the protein extracts were immunoprecipitated by anti-ABIN-3 antibody to identify the protein that potentially interacts with ABIN-3.

Results

The activation of NF-kappa B pathway coincided with granuloma development, while A20 and ABIN-3 increased in accordance with granuloma regression. TAK-1 protein was co-precipitated with ABIN-3 by immunoprecipitation using anti-ABIN-3 antibody.

Conclusion

The results suggest that ABIN-3 contributed to granuloma regression by interacting with TAK-1 and, as a consequence, inhibiting activation of NF-kappa B pathway.
Literature
1.
go back to reference WHO. Global tuberculosis control; epidemiology, strategy, financing. WHO report. Geneva: World Health Organization; 2009. WHO. Global tuberculosis control; epidemiology, strategy, financing. WHO report. Geneva: World Health Organization; 2009.
2.
go back to reference Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3:231–79. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3:231–79.
3.
go back to reference Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis. 2008;21:587–95.PubMedCrossRef Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis. 2008;21:587–95.PubMedCrossRef
4.
go back to reference Migliori GB, Centis R, Lange C, Richardson MD, Sotgiu G. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspective. Curr Opin Pulm Med. 2010;16:171–9.PubMed Migliori GB, Centis R, Lange C, Richardson MD, Sotgiu G. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspective. Curr Opin Pulm Med. 2010;16:171–9.PubMed
5.
go back to reference Monedero I, Caminero JA. Management of multidrug-resistant tuberculosis: an update. Ther Adv Respir Dis. 2010;4:117–27.PubMedCrossRef Monedero I, Caminero JA. Management of multidrug-resistant tuberculosis: an update. Ther Adv Respir Dis. 2010;4:117–27.PubMedCrossRef
6.
go back to reference Lienhardt C, Vernon A, Raviglione MC. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implication for national programmes. Curr Opin Pulm Med. 2010;16:186–93.PubMed Lienhardt C, Vernon A, Raviglione MC. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implication for national programmes. Curr Opin Pulm Med. 2010;16:186–93.PubMed
7.
go back to reference Quitang L, Inder MV. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725–35.CrossRef Quitang L, Inder MV. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725–35.CrossRef
8.
go back to reference Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:111–37.CrossRef Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:111–37.CrossRef
9.
go back to reference Billack B. Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am J Pharm Educ. 2006;70:102.PubMedCrossRef Billack B. Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am J Pharm Educ. 2006;70:102.PubMedCrossRef
10.
go back to reference Gerondakis S, Grossmann M, Nakamura Y, Pohi T, Gurmort R. Genetic approaches in mice to understand Rel/NF-kappaB and I-kappaB function; transgenic and knockouts. Oncogene. 1999;18:6888–95.PubMedCrossRef Gerondakis S, Grossmann M, Nakamura Y, Pohi T, Gurmort R. Genetic approaches in mice to understand Rel/NF-kappaB and I-kappaB function; transgenic and knockouts. Oncogene. 1999;18:6888–95.PubMedCrossRef
11.
go back to reference Darieva Z, Lasunskaia EB, Campos MN, Kipnis TL, DaSalva WD. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhance NF-kappa B-dependent gene transcription in BCG-stimulated macrophages through promoter p65/p300 binding. J Leukoc Biol. 2004;75:689–97.PubMedCrossRef Darieva Z, Lasunskaia EB, Campos MN, Kipnis TL, DaSalva WD. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhance NF-kappa B-dependent gene transcription in BCG-stimulated macrophages through promoter p65/p300 binding. J Leukoc Biol. 2004;75:689–97.PubMedCrossRef
12.
go back to reference Morris KR, Lutz RD, Choi HS, Kamitani T, Chmura K, Chan ED. Role of NF-kappa B signaling pathway and kappa B cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun. 2003;71:1442–52.PubMedCrossRef Morris KR, Lutz RD, Choi HS, Kamitani T, Chmura K, Chan ED. Role of NF-kappa B signaling pathway and kappa B cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun. 2003;71:1442–52.PubMedCrossRef
13.
go back to reference Marakalala MJ, Graham LM, Brown GD. The role of Syk/Card9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections. Clin Dev Immunol. 2010;2010:567594.CrossRef Marakalala MJ, Graham LM, Brown GD. The role of Syk/Card9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections. Clin Dev Immunol. 2010;2010:567594.CrossRef
14.
go back to reference Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med. 2009;206:2879–88.PubMedCrossRef Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med. 2009;206:2879–88.PubMedCrossRef
15.
go back to reference Perkins ND. Post-transcriptional modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25:6717–30.PubMedCrossRef Perkins ND. Post-transcriptional modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25:6717–30.PubMedCrossRef
16.
go back to reference Heyninck K, Beyaert R. A20 inhibits NF-kappa B activation by dual ubiquitin-editing functions. Trends Biochem Sci. 2005;30:1–4.PubMedCrossRef Heyninck K, Beyaert R. A20 inhibits NF-kappa B activation by dual ubiquitin-editing functions. Trends Biochem Sci. 2005;30:1–4.PubMedCrossRef
17.
go back to reference Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Lohr F, Wu CJ, Dotsch V, Dikic I, Bayaert R. Ubiquitin binding mediates the NF-kappa B inhibitory potential of ABIN proteins. Oncogene. 2008;27:3739–45.PubMedCrossRef Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Lohr F, Wu CJ, Dotsch V, Dikic I, Bayaert R. Ubiquitin binding mediates the NF-kappa B inhibitory potential of ABIN proteins. Oncogene. 2008;27:3739–45.PubMedCrossRef
18.
go back to reference Staege H, Brauchlin A, Schoedon G, Schaffner A. Two novel genes FIND and LIND differentially expressed in deactivated and Listeria-infected macrophages. Immunogenetics. 2001;53:105–13.PubMedCrossRef Staege H, Brauchlin A, Schoedon G, Schaffner A. Two novel genes FIND and LIND differentially expressed in deactivated and Listeria-infected macrophages. Immunogenetics. 2001;53:105–13.PubMedCrossRef
19.
go back to reference Wullaert A, Verstrepen L, Huffel SV, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, Bakkouri KE, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaer R. LIND/ABIN-3 is a novel lipopolysaccharide-induced inhibitor of NF-kappa-B activation. J Biol Chem. 2007;282:81–90.PubMedCrossRef Wullaert A, Verstrepen L, Huffel SV, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, Bakkouri KE, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaer R. LIND/ABIN-3 is a novel lipopolysaccharide-induced inhibitor of NF-kappa-B activation. J Biol Chem. 2007;282:81–90.PubMedCrossRef
20.
go back to reference Verhelst K, Verstrepen L, Coornaert B, Carptentier I, Beyaer R. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation. Methods Mol Biol. 2009;78:105–14. Verhelst K, Verstrepen L, Coornaert B, Carptentier I, Beyaer R. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation. Methods Mol Biol. 2009;78:105–14.
21.
go back to reference Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R. Expression of the NF-kappa B inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappa B. J Cell Mol Med. 2008;12:316–29.PubMedCrossRef Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R. Expression of the NF-kappa B inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappa B. J Cell Mol Med. 2008;12:316–29.PubMedCrossRef
22.
go back to reference Mauro C, Pacifico F, Lavorgna A, Mellone S, Lannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A. ABIN-1 binds to NEMO/IKK-gamma and co-operates with A20 in inhibiting NF-kappa-B. J Biol Chem. 2006;281:18482–8.PubMedCrossRef Mauro C, Pacifico F, Lavorgna A, Mellone S, Lannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A. ABIN-1 binds to NEMO/IKK-gamma and co-operates with A20 in inhibiting NF-kappa-B. J Biol Chem. 2006;281:18482–8.PubMedCrossRef
23.
go back to reference Hughes DP, Marron MB, Brindle NP. The anti-inflammatory endothelial tyrosin kinase Tie-2 interact with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res. 2003;92:630–6.PubMedCrossRef Hughes DP, Marron MB, Brindle NP. The anti-inflammatory endothelial tyrosin kinase Tie-2 interact with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res. 2003;92:630–6.PubMedCrossRef
24.
go back to reference Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S, Howell S, Ley SC. ABIN-2 forms a ternary complex with TPL-2 and NF-kappaB1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol. 2004;24:5235–48.PubMedCrossRef Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S, Howell S, Ley SC. ABIN-2 forms a ternary complex with TPL-2 and NF-kappaB1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol. 2004;24:5235–48.PubMedCrossRef
25.
go back to reference Kolattukdy PE, Fernandes ND, Azad AK, Fitzmaurice AM, Sirakova TD. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol. 1997;69:263–70.CrossRef Kolattukdy PE, Fernandes ND, Azad AK, Fitzmaurice AM, Sirakova TD. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol. 1997;69:263–70.CrossRef
26.
27.
go back to reference Hamasaki N, Isowa K, Kamada K, Terao Y, Matsumoto T, Arakawa T, Kobayashi K. In vivo administration of mycobacterial cord factor (Trehalose 6,6′-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits. Infect Immun. 2000;68:3704–9.PubMedCrossRef Hamasaki N, Isowa K, Kamada K, Terao Y, Matsumoto T, Arakawa T, Kobayashi K. In vivo administration of mycobacterial cord factor (Trehalose 6,6′-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits. Infect Immun. 2000;68:3704–9.PubMedCrossRef
28.
go back to reference Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryqqvason K, Gordon S, Russell DG. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 2009;5:e1000474.PubMedCrossRef Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryqqvason K, Gordon S, Russell DG. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 2009;5:e1000474.PubMedCrossRef
29.
go back to reference Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, Yano I, Kobayashi K. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign body and hypersensitivity type granulomas in mice. Infect Immun. 2001;69:810–5.PubMedCrossRef Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, Yano I, Kobayashi K. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign body and hypersensitivity type granulomas in mice. Infect Immun. 2001;69:810–5.PubMedCrossRef
30.
go back to reference Sakai Y, Uchida K, Nakayama H. Histopathological features and expression profiles of cytokines, chemokines and SOCS family proteins in trehalose 6,6′-dimycolate induced granulomatous lesions. Inflamm Res. 2011;60:371–8.PubMedCrossRef Sakai Y, Uchida K, Nakayama H. Histopathological features and expression profiles of cytokines, chemokines and SOCS family proteins in trehalose 6,6′-dimycolate induced granulomatous lesions. Inflamm Res. 2011;60:371–8.PubMedCrossRef
31.
go back to reference Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S. TAK1, but not TAB 1 or TAB 2, plays and essential role in multiple signaling pathway in vivo. Genes Dev. 2005;19:2668–81.PubMedCrossRef Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S. TAK1, but not TAB 1 or TAB 2, plays and essential role in multiple signaling pathway in vivo. Genes Dev. 2005;19:2668–81.PubMedCrossRef
32.
go back to reference O’Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol. 2002;270:47–61.PubMedCrossRef O’Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol. 2002;270:47–61.PubMedCrossRef
33.
go back to reference Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science. 1995;270:2008–11.PubMedCrossRef Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science. 1995;270:2008–11.PubMedCrossRef
34.
go back to reference Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K. TAB-2, a novel adaptor protein, mediates activation of TAK-1 MAPKKK by linking TAK-1 to TRAF-6 in the IL-1 signal transduction pathway. Mol Cell. 2000;5:649–58.PubMedCrossRef Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K. TAB-2, a novel adaptor protein, mediates activation of TAK-1 MAPKKK by linking TAK-1 to TRAF-6 in the IL-1 signal transduction pathway. Mol Cell. 2000;5:649–58.PubMedCrossRef
35.
go back to reference Takaesu G, Surabhi RM, Park KJ, Ninoyama-Tsuji J, Matsumoto K, Gaynor RB. TAK-1 is critical for IκB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol. 2003;326:105–15.PubMedCrossRef Takaesu G, Surabhi RM, Park KJ, Ninoyama-Tsuji J, Matsumoto K, Gaynor RB. TAK-1 is critical for IκB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol. 2003;326:105–15.PubMedCrossRef
36.
go back to reference Wang C, Deng L, Hong M, Akkaraju G, Inoue J, Chen ZJ. TAK-1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412:346–51.PubMedCrossRef Wang C, Deng L, Hong M, Akkaraju G, Inoue J, Chen ZJ. TAK-1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412:346–51.PubMedCrossRef
37.
go back to reference Wertz EZ, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling. Nature. 2000;430:694–9.CrossRef Wertz EZ, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling. Nature. 2000;430:694–9.CrossRef
38.
go back to reference Malynn BA, Ma A. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J Exp Med. 2009;206:977–80.PubMedCrossRef Malynn BA, Ma A. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J Exp Med. 2009;206:977–80.PubMedCrossRef
39.
go back to reference Huang H, Tang QZ, Wang AB, Chen M, Yan L, Liu C, Jiang H, Yang Q, Biang ZY, Bai X, Zhu LH, Wang L, Li H. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension. 2010;56:232–9.PubMedCrossRef Huang H, Tang QZ, Wang AB, Chen M, Yan L, Liu C, Jiang H, Yang Q, Biang ZY, Bai X, Zhu LH, Wang L, Li H. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension. 2010;56:232–9.PubMedCrossRef
40.
go back to reference Vereecke L, Beyaert R, van-Loo G. The ubiquitin-editing enzyme A20 (TNFAIP-3) is a central regulator of immunopathology. Trends Immunol. 2009;30:383–91.PubMedCrossRef Vereecke L, Beyaert R, van-Loo G. The ubiquitin-editing enzyme A20 (TNFAIP-3) is a central regulator of immunopathology. Trends Immunol. 2009;30:383–91.PubMedCrossRef
41.
go back to reference Heyninck K, DeValck D, Berghe WV, Van Criekinge W, Contreras R, Fiers W. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2- mediated transactivation signal and directly bind to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol. 1999;145:1471–82.PubMedCrossRef Heyninck K, DeValck D, Berghe WV, Van Criekinge W, Contreras R, Fiers W. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2- mediated transactivation signal and directly bind to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol. 1999;145:1471–82.PubMedCrossRef
42.
go back to reference Verstrepen L, Carpentier I, Verhelst K, Beyaert R. ABINs: A20 binding inhibitors of NF-kappaB and apoptosis signaling. Biochem Pharmacol. 2009;78:105–14.PubMedCrossRef Verstrepen L, Carpentier I, Verhelst K, Beyaert R. ABINs: A20 binding inhibitors of NF-kappaB and apoptosis signaling. Biochem Pharmacol. 2009;78:105–14.PubMedCrossRef
43.
go back to reference Weaver BK, Bohn E, Judd BA, Gill MP, Schreiber RD. ABIN-3: a molecular basis for species divergence in interleukin-10 induced anti-inflammatory actions. Mol Cell Biol. 2007;27:4603–16.PubMedCrossRef Weaver BK, Bohn E, Judd BA, Gill MP, Schreiber RD. ABIN-3: a molecular basis for species divergence in interleukin-10 induced anti-inflammatory actions. Mol Cell Biol. 2007;27:4603–16.PubMedCrossRef
44.
go back to reference Chakravarty SD, Tsai MC, Mohan VP, Marino S, Kirschner DE, Huang L, Flynn J, Chan J. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lung. Infect Immun. 2008;76:916–26.PubMedCrossRef Chakravarty SD, Tsai MC, Mohan VP, Marino S, Kirschner DE, Huang L, Flynn J, Chan J. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lung. Infect Immun. 2008;76:916–26.PubMedCrossRef
45.
go back to reference Fremond CM, Togbe D, Rose S, Vasseur V, Maillet I, Jacob M, Ryffel B, Quesniaux VF. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol. 2007;179:1178–89.PubMed Fremond CM, Togbe D, Rose S, Vasseur V, Maillet I, Jacob M, Ryffel B, Quesniaux VF. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol. 2007;179:1178–89.PubMed
46.
go back to reference Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.PubMedCrossRef Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.PubMedCrossRef
47.
go back to reference Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, Bouchard P, George MD, Hu WK, Dandekar S, Smith PD. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaB alpha expression and NF-kappa B inactivation. J Biol Chem. 2010;285:19593–604.PubMedCrossRef Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, Bouchard P, George MD, Hu WK, Dandekar S, Smith PD. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaB alpha expression and NF-kappa B inactivation. J Biol Chem. 2010;285:19593–604.PubMedCrossRef
48.
go back to reference Ogawa K, Fubada M, Tsujimoto M. Suppression of NF-kappa B and IRF-1-induced transcription of the murine IL-12 p40 by transforming growth factor-beta Smad pathway in macrophages. Mol Cell Biochem. 2008;308:9–15.PubMedCrossRef Ogawa K, Fubada M, Tsujimoto M. Suppression of NF-kappa B and IRF-1-induced transcription of the murine IL-12 p40 by transforming growth factor-beta Smad pathway in macrophages. Mol Cell Biochem. 2008;308:9–15.PubMedCrossRef
49.
go back to reference Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol. 2008;10:1179–88.CrossRef Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol. 2008;10:1179–88.CrossRef
50.
go back to reference Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci USA. 2009;106:1897–902.PubMedCrossRef Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci USA. 2009;106:1897–902.PubMedCrossRef
51.
go back to reference Bugarcic A, Hitchens K, Beckhouse AG, Wells CA, Ashman RB, Blanchard H. Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans. Glycobiology. 2008;18:679–85.PubMedCrossRef Bugarcic A, Hitchens K, Beckhouse AG, Wells CA, Ashman RB, Blanchard H. Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans. Glycobiology. 2008;18:679–85.PubMedCrossRef
52.
go back to reference Düwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U, Darnay BG, Ruland J, Marynen P, Krappmann D. A20 negatively regulates T cell receptor signaling to NF-kappa B by cleaving Malt1 ubiquitin chains. J Immunol. 2009;182:7718–28.PubMedCrossRef Düwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U, Darnay BG, Ruland J, Marynen P, Krappmann D. A20 negatively regulates T cell receptor signaling to NF-kappa B by cleaving Malt1 ubiquitin chains. J Immunol. 2009;182:7718–28.PubMedCrossRef
Metadata
Title
A20 and ABIN-3 possibly promote regression of trehalose 6,6′-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1
Authors
Yusuke Sakai
Kazuyuki Uchida
Hiroyuki Nakayama
Publication date
01-03-2012
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 3/2012
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0406-6

Other articles of this Issue 3/2012

Inflammation Research 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.